FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Paul Antony

Research Profile

Living Beings

Anatomy

Procedures

Disorders

Chemicals & Drugs

Physiology

Co-author Network

Publications

TOP 3
Stephen R Goding; Kristina M Harris; Scott E Strome; Koji Tamada; Kyle A Wilson; Ying Xie; Akgül Akpinarli; Aparna Baxi; Amy Fulton; Paul A Antony
Restoring Immune Function of Tumor-Specific CD4+ T Cells during Recurrence of Melanoma.
Shawn M Jensen; May Lim; Levi D Maston; Ulf Petrausch; Nicholas P Restifo; Christopher G Twitty; Paul A Antony; Hong-Ming Hu; Bernard A Fox
Increased frequency of suppressive regulatory T cells and T cell-mediated antigen loss results in murine melanoma recurrence.
Pawel Muranski; Christopher A Klebanoff; Wei Shen; Steven J Kern; Madhusudhanan Sukumar; Arian Dominic John laurence; Douglas C Palmer; Robert L Danner; Zachary A Borman; Yun Ji; Sid P Kerkar; Zhiya Yu; Luis Sanchez-Perez; Rahul Roychoudhuri; Paul A Antony; Robert N Reger; Scott K Durum; Luca Gattinoni; Chi-Chao Chan; Lionel Feigenbaum; Gabriela A Ferreyra; Nicholas P Restifo
Th17 cells are long lived and retain a stem cell-like molecular signature.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Paul Antony (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Stephen R Goding; Kristina M Harris; Scott E Strome; Koji Tamada; Kyle A Wilson; Ying Xie; Akgül Akpinarli; Aparna Baxi; Amy Fulton; Paul A Antony
Restoring Immune Function of Tumor-Specific CD4+ T Cells during Recurrence of Melanoma.
Journal of immunology (Baltimore, Md. : 1950) 2013;190(9):4899-909.
2012: Shawn M Jensen; May Lim; Levi D Maston; Ulf Petrausch; Nicholas P Restifo; Christopher G Twitty; Paul A Antony; Hong-Ming Hu; Bernard A Fox
Increased frequency of suppressive regulatory T cells and T cell-mediated antigen loss results in murine melanoma recurrence.
Journal of immunology (Baltimore, Md. : 1950) 2012;189(2):767-76.
2011: Pawel Muranski; Christopher A Klebanoff; Wei Shen; Steven J Kern; Madhusudhanan Sukumar; Arian Dominic John laurence; Douglas C Palmer; Robert L Danner; Zachary A Borman; Yun Ji; Sid P Kerkar; Zhiya Yu; Luis Sanchez-Perez; Rahul Roychoudhuri; Paul A Antony; Robert N Reger; Scott K Durum; Luca Gattinoni; Chi-Chao Chan; Lionel Feigenbaum; Gabriela A Ferreyra; Nicholas P Restifo
Th17 cells are long lived and retain a stem cell-like molecular signature.
Immunity 2011;35(6):972-85.
2010: Matthew P Rausch; Kari R Irvine; Paul A Antony; Nicholas P Restifo; Peter Cresswell; K Taraszka Hastings
GILT accelerates autoimmunity to the melanoma antigen tyrosinase-related protein 1.
Journal of immunology (Baltimore, Md. : 1950) 2010;185(5):2828-35.
2010: Ying Xie; Akgül Akpinarli; Charles Maris; Edward L Hipkiss; Malcolm Lane; Eun-Kyung M Kwon; Pawel Muranski; Nicholas P Restifo; Paul A Antony
Naive tumor-specific CD4(+) T cells differentiated in vivo eradicate established melanoma.
The Journal of experimental medicine 2010;207(3):651-67.
2010: Sergio Quezada; Tyler R Simpson; Karl S Peggs; Taha Merghoub; Jelena Vider; Xiaozhou Fan; Ronald Blasberg; Hideo Yagita; Pawel Muranski; Paul A Antony; Nicholas P Restifo; James P Allison
Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts.
The Journal of experimental medicine 2010;207(3):637-50.
2008: Pawel Muranski; Andrea Boni; Paul A Antony; Lydie Cassard; Kari R Irvine; Andrew Kaiser; Chrystal M Paulos; Douglas Palmer; Christopher E Touloukian; Krzysztof Ptak; Luca Gattinoni; Claudia Wrzesinski; Christian S Hinrichs; Keith W Kerstann; Lionel Feigenbaum; Chi-Chao Chan; Nicholas P Restifo
Tumor-specific Th17-polarized cells eradicate large established melanoma.
Blood 2008;112(2):362-73.
2007: Chrystal M Paulos; Andrew Kaiser; Claudia Wrzesinski; Christian S Hinrichs; Lydie Cassard; Andrea Boni; Pawel Muranski; Luis Sanchez-Perez; Douglas Palmer; Zhiya Yu; Paul A Antony; Luca Gattinoni; STEVEN ROSENBERG; Nicholas P Restifo
Toll-like receptors in tumor immunotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(18 Pt 1):5280-9.
2007: Chrystal M Paulos; Claudia Wrzesinski; Andrew Kaiser; Christian S Hinrichs; Marcello Chieppa; Lydie Cassard; Douglas Palmer; Andrea Boni; Pawel Muranski; Zhiya Yu; Luca Gattinoni; Paul A Antony; STEVEN ROSENBERG; Nicholas P Restifo
Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling.
The Journal of clinical investigation 2007;117(8):2197-204.
2007: Mojgan Ahmadzadeh; Paul A Antony; STEVEN ROSENBERG
IL-2 and IL-15 each mediate de novo induction of FOXP3 expression in human tumor antigen-specific CD8 T cells.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2007;30(3):294-302.
2006: Luca Gattinoni; Anju Ranganathan; Deborah R Surman; Douglas Palmer; Paul A Antony; Marc R Theoret; David M Heimann; STEVEN ROSENBERG; Nicholas P Restifo
CTLA-4 dysregulation of self/tumor-reactive CD8+ T-cell function is CD4+ T-cell dependent.
Blood 2006;108(12):3818-23.
2006: Paul A Antony; Chrystal M Paulos; Mojgan Ahmadzadeh; Akgül Akpinarli; Douglas Palmer; Noriko Sato; Andrew Kaiser; Christian S Hinrichs; Christian Heinrichs; Christopher A Klebanoff; Yutaka Tagaya; Nicholas P Restifo
Interleukin-2-dependent mechanisms of tolerance and immunity in vivo.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(9):5255-66.
2005: Luca Gattinoni; Steven E Finkelstein; Christopher A Klebanoff; Paul A Antony; Douglas Palmer; Paul J Spiess; Leroy N Hwang; Zhiya Yu; Claudia Wrzesinski; David M Heimann; Charles D Surh; STEVEN ROSENBERG; Nicholas P Restifo
Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells.
The Journal of experimental medicine 2005;202(7):907-12.
2005: Christopher A Klebanoff; Luca Gattinoni; Parizad Torabi-Parizi; Kimberly F Kerstann; Adela R Cardones; Steven E Finkelstein; Douglas Palmer; Paul A Antony; Sam T Hwang; STEVEN ROSENBERG; Thomas Waldmann; Nicholas P Restifo
Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(27):9571-6.
2005: Paul A Antony; Ciriaco Piccirillo; Akgül Akpinarli; Steven E Finkelstein; Paul J Speiss; Deborah R Surman; Douglas Palmer; Chi-Chao Chan; Christopher A Klebanoff; Willem W Overwijk; STEVEN ROSENBERG; Nicholas P Restifo
CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(5):2591-601.
2005: Paul A Antony; Nicholas P Restifo
CD4+CD25+ T regulatory cells, immunotherapy of cancer, and interleukin-2.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2005;28(2):120-8.
2005: Christopher A Klebanoff; Hung T Khong; Paul A Antony; Douglas Palmer; Nicholas P Restifo
Sinks, suppressors and antigen presenters: how lymphodepletion enhances T cell-mediated tumor immunotherapy.
Trends in immunology 2005;26(2):111-7.
2004: Steven E Finkelstein; David M Heimann; Christopher A Klebanoff; Paul A Antony; Luca Gattinoni; Christian S Hinrichs; Leroy N Hwang; Douglas Palmer; Paul J Spiess; Deborah R Surman; Claudia Wrzesiniski; Zhiya Yu; STEVEN ROSENBERG; Nicholas P Restifo
Bedside to bench and back again: how animal models are guiding the development of new immunotherapies for cancer.
Journal of leukocyte biology 2004;76(2):333-7.
2004: Hua Yang; Paul A Antony; Barbara E Wildhaber; Daniel H Teitelbaum
Intestinal intraepithelial lymphocyte gamma delta-T cell-derived keratinocyte growth factor modulates epithelial growth in the mouse.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(7):4151-8.
2004: Christopher A Klebanoff; Steven E Finkelstein; Deborah R Surman; Michael K Lichtman; Luca Gattinoni; Marc R Theoret; Navrose Grewal; Paul J Spiess; Paul A Antony; Douglas Palmer; Yutaka Tagaya; STEVEN ROSENBERG; Thomas Waldmann; Nicholas P Restifo
IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(7):1969-74.
2003: Willem W Overwijk; Marc R Theoret; Steven E Finkelstein; Deborah R Surman; Laurina A de Jong; Florry A Vyth-Dreese; Trees A Dellemijn; Paul A Antony; Paul J Spiess; Douglas Palmer; David M Heimann; Christopher A Klebanoff; Zhiya Yu; Leroy N Hwang; Lionel Feigenbaum; Ada M Kruisbeek; STEVEN ROSENBERG; Nicholas P Restifo
Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells.
The Journal of experimental medicine 2003;198(4):569-80.
2002: Hua Yang; Irfan Kiristioglu; Yongyi Fan; Benjamin Forbush; D Keith Bishop; Paul A Antony; Hong Zhou; Daniel H Teitelbaum
Interferon-gamma expression by intraepithelial lymphocytes results in a loss of epithelial barrier function in a mouse model of total parenteral nutrition.
Annals of surgery 2002;236(2):226-34.
2002: Irfan Kiristioglu; Paul A Antony; Yongyi Fan; Benjamin Forbush; R Lee Mosley; Hua Yang; Daniel H Teitelbaum
Total parenteral nutrition-associated changes in mouse intestinal intraepithelial lymphocytes.
Digestive diseases and sciences 2002;47(5):1147-57.
2002: Paul A Antony; Nicholas P Restifo
Do CD4+ CD25+ immunoregulatory T cells hinder tumor immunotherapy?
Journal of immunotherapy (Hagerstown, Md. : 1997) 2002;25(3):202-6.
2002: Nicholas P Restifo; Paul A Antony; Steven E Finkelstein; Wolfgang W Leitner; Deborah P Surman; Marc R Theoret; Christopher E Touloukian
Assumptions of the tumor 'escape' hypothesis.
Seminars in cancer biology 2002;12(1):81-6.
1997: Anita H Kirsch; Luis Alberto Diaz; B Bonish; Paul A Antony; David A Fox
The pattern of expression of CD147/neurothelin during human T-cell ontogeny as defined by the monoclonal antibody 8D6.
Tissue antigens 1997;50(2):147-52.